Online citations, reference lists, and bibliographies.
← Back to Search

N Omega-hydroxy-L-arginine Is An Intermediate In The Biosynthesis Of Nitric Oxide From L-arginine.

D. Stuehr, N. S. Kwon, C. Nathan, O. Griffith, P. Feldman, J. Wiseman
Published 1991 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Authentic N omega-hydroxy-L-arginine was synthesized and used to determine whether it is an intermediate in nitric oxide (.NO) synthesis from L-arginine by macrophage .NO synthase. The apparent Km (6.6 microM) and Vmax (99 nmol x min-1 x mg-1) observed with N omega-hydroxy-L-arginine were similar to those observed with L-arginine (Km = 2.3 microM; Vmax = 54 mumol x min-1 x mg-1). N omega-Hydroxy-D-arginine was not a substrate. Stable isotope studies showed that .NO synthase exclusively oxidized the hydroxylated nitrogen of N omega-hydroxy-L-arginine, forming .NO and L-citrulline. As with L-arginine, O2 was the source of the ureido oxygen in L-citrulline from N omega-hydroxy-L-arginine. In the presence of excess N omega-hydroxy-L-arginine, .NO synthase generated a metabolite of L-[14C]arginine that cochromatographed with authentic N omega-hydroxy-L-arginine. The labeled metabolite exhibited identical chromatographic behavior in three solvent systems and generated the same product (L-citrulline) upon alkaline hydrolysis as authentic N omega-hydroxy-L-arginine. Experiments were then run to identify which redox cofactor (NADPH or tetrahydrobiopterin) participated in the enzymatic synthesis of N omega-hydroxy-L-arginine. Both cofactors were required for synthesis of .NO from either N omega-hydroxy-L-arginine or L-arginine. However, with L-arginine, the synthesis of 1 mol of .NO was coupled to the oxidation of 1.52 +/- 0.02 mol of NADPH; whereas with N omega-hydroxy-L-arginine, only 0.53 +/- 0.04 mol of NADPH was oxidized per mol of .NO formed. These results support a mechanism in which N omega-hydroxy-L-arginine is generated as an intermediate in .NO synthesis through an NADPH-dependent hydroxylation of L-arginine.
This paper references

This paper is referenced by
Potentiation of the vasorelaxant activity of nitric oxide by hydroxyguanidine: implications for the nature of endothelium‐derived relaxing factor
A. Zembowicz (1992)
Do Deficiencies of Endothelial Derived Relaxing Factor Contribute to Myocardial Stunning?
A. Wallace (1993)
Failure to prevent selective CA1 neuronal death and reduce cortical infarction following cerebral ischemia with inhibition of nitric oxide synthase
A. Buchan (1994)
Characterization of Heme-deficient Neuronal Nitric-oxide Synthase Reveals a Role for Heme in Subunit Dimerization and Binding of the Amino Acid Substrate and Tetrahydrobiopterin (*)
P. Klatt (1996)
Oxytocin stimulates cerebral blood flow in rainbow trout (Oncorhynchus mykiss) through a nitric oxide dependent mechanism
Lene Haraldsen (2002)
Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?
C. Morris (2003)
Models and Mechanisms of Cytochrome P450 Action
J. Groves (2005)
Control of electron transfer in neuronal nitric oxide synthase by calmodulin, substrate, substrate analogs, and nitric oxide.
D. Stuehr (1995)
Ascorbic Acid Enhances Endothelial Nitric-oxide Synthase Activity by Increasing Intracellular Tetrahydrobiopterin*
A. Huang (2000)
The Inhibition of Arginase by N ω-Hydroxy-l-Arginine Controls the Growth of Leishmania Inside Macrophages
V. Iniesta (2001)
Nitric oxide synthases: structure, function and inhibition.
W. K. Alderton (2001)
Efecto de la coartación aórtica en la producción de óxido nítrico por el endotelio vascular
Sonia Ovelí Martínez Ayala (1998)
Production and scavenging of nitric oxide by barley root mitochondria.
K. J. Gupta (2010)
[19] - Nitric Oxide and Endothelial Regulation of Vascular Tone
F. Cosentino (1996)
The Defective Arginine-Nitric Oxide Pathway in Sickle Cell Disease
C. Morris (2017)
Cytochrome P450-dependent N-hydroxylation of an aminoguanidine (amidinohydrazone) and microsomal retroreduction of the N-hydroxylated product.
B. Clement (1994)
Effects of Asp-369 and Arg-372 Mutations on Heme Environment and Function in Human Endothelial Nitric-oxide Synthase*
P. Chen (1998)
Macrophage nitric oxide synthase: relationship between enzyme-bound tetrahydrobiopterin and synthase activity.
J. Hevel (1992)
Aromatic N-hydroxyguanidines as new reduction cosubstrates for dopamine beta-hydroxylase.
P. Slama (2004)
iNOS-mediated nitric oxide production and its regulation.
F. Aktan (2004)
Nitric-oxide Synthase Output State
D. Ghosh (2006)
Nitric oxide, a biological double-faced janus--is this good or bad?
T. Thippeswamy (2006)
Fast ferrous heme–NO oxidation in nitric oxide synthases
J. Tejero (2009)
Influence of dietary nitrate food forms on nitrate metabolism and blood pressure in healthy normotensive adults.
S. McDonagh (2018)
Chapter 8. EDRF, an Emerging Target for Drug Design
J. Kerwin (1992)
Guanylyl cyclases, a growing family of signal‐transducing enzymes
D. Koesling (1991)
The molecular mechanism of mammalian NO-synthases: a story of electrons and protons.
J. Santolini (2011)
Chapter 9. The Enzymology and Manipulation of Nitric Oxide Synthase
Jon M. Fukuto (1994)
Multiphotonic study of a new NADPH-derivative compound targeting NO-synthase
H. Wang (2013)
Regulation of nitric oxide synthase and soluble guanylyl cyclase
Bernd Mayer (1994)
Identification of Nitric Oxide Synthase as a Thiolate-ligated Heme Protein Using Magnetic Circular Dichroism Spectroscopy
M. Sono (1995)
Heme Iron Reduction and Catalysis by a Nitric Oxide Synthase Heterodimer Containing One Reductase and Two Oxygenase Domains (*)
U. Siddhanta (1996)
See more
Semantic Scholar Logo Some data provided by SemanticScholar